Europe is rewriting its tobacco rules: what must change for allergy, asthma and COPD patients
As the EU prepares to revise its rules on tobacco products and advertising, EFA is calling for stronger and more consistent regulation of tobacco and nicotine...
Breathe Better, Get Your Vaccine: EFA launches new patient manifesto for fairer access to vaccination
Respiratory infections can hit people living with asthma, COPD, respiratory allergies and other chronic respiratory diseases particularly hard. Yet across...
What can healthcare in your country do to #BreakTheInvisibleBurden of atopic eczema? New EFA policy recommendations at the policy session in Vienna
Atopic eczema affects much more than the skin. It can disrupt sleep, mental health, relationships, school and work, while also creating significant costs...
EU plans new rules on smoking treatment, with greater focus on nicotine, novel products and addiction – EFA Community responds
Europe’s nicotine market has changed dramatically since the EU last updated its guidance on medicines to help people stop smoking in 2009.
Electronic...
Breaking the invisible burden of atopic eczema at the European Health Forum Gastein 2026
In collaboration with the World Skin Health Coalition, EFA brought the invisible burden of chronic non-communicable diseases at the European Health Forum...
Press Release: On World Atopic Eczema Day 2026 let’s #BreakTheInvisibleBurden
Brussels, 14 September 2026 - On 14 September, World Atopic Eczema Day, patient communities around the world are coming together to raise awareness on...
The EU Biotech Act is moving forward: three patient priorities Europe should not overlook
Europe is one step closer to adopting its first law focused on health biotechnology. For patients with allergy, asthma, COPD and atopic eczema the question...
EFA marks EMA’s 30th anniversary and two decades of patient involvement
The European Medicine’s Agency (EMA) celebrated two important milestones: its 30th anniversary and 20 years of activity of the Patients’ and Consumers’...
Why Europe needs a European Lung Health Plan – new infographic by the European Lung Health Group
For the millions of people across Europe living with respiratory allergy, asthma, COPD and other lung diseases, lung health is shaped by far more than...
EFA brings the food allergy patient voice to global discussions on allergen labelling at CCFL49
Clear and reliable food labelling is essential for people living with food allergy. For patients and families, allergen information is not only a consumer...
Strength in unity - Irish Presidency of the EU Council sets strong health ambitions
On 1 July 2026, Ireland kicked off the Presidency of the Council of the European Union from Cyprus. Until December, the Irish Executive will lead negotiations...
EFA Annual Impact Report 2025 is now available!
EFA has published its Annual Impact Report 2025, looking back at a year of stronger patient advocacy, deeper community engagement and growing action on...
EFA at the SynAir-G workshop: connecting data, patients and policy on indoor air quality in schools
On 8 June 2026 in Brussels, EFA joined the SynAir-G third workshop "Smart Synergies for Action: Connecting Data, Patients and Policy on Indoor Air Quality."...
EFA and SynAir-G project discuss the importance of indoor air quality and children’s health at the European Parliament
On 11 June 2026, EFA joined forces with the EU-funded SynAir-G project at the European Parliament for a roundtable on indoor air quality and children's...
EU’s proposal to restrict PFAS might be a threat for patients relying on inhaled medicines
Per- and polyfluoroalkyl substances, or PFAS, a broad group of chemicals often referred to as “forever chemicals”, raise serious environmental and...
EFA Community marks World Asthma Day 2026 with #EmpoweredToBreathe and practical information for daily life with asthma
Today, on 5 May, the EFA Community marks World Asthma Day 2026 under the theme #EmpoweredToBreathe – taking control of asthma every day.
Across...
EFA’s take on EMA’s updates on clinical trials during public health emergencies in Europe
Imagine you are a patient participating in a clinical trial and half-way through it is modified or postponed due...
Celebrating 35 Years of EFA: new leadership and a growing patient community at the AGM and Community Meeting in Malta
The EFA Community gathered in Malta for its Annual General Meeting and Community Meeting, hosted by the Malta Eczema Society. 31 member organisations from...
Three EFA community asks on EMA’s patient experience data
Medicines are assessed on quality, safety and efficacy. Patients and carers experience the full picture: what improves day to day, what trade-offs come...
EFA community priorities for an EU framework on climate resilience and risk management
Europe is already feeling the climate crisis. The continent is warming twice as fast as the global average, which means more frequent and intense heatwaves,...